Wujin Sun

Wujin Sun


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2018 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
ZLZhimin Luo
Zhimin Luo
WSWujin Sun
Wujin Sun
JFJun Fang
Jun Fang
KLKangJu Lee
KangJu Lee
SLSong Li
Song Li
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

14 April 2022 in Biomaterials
Verified
Journal Article
Closed access
CWCanran Wang
Canran Wang
XJXing Jiang
Xing Jiang
HKHanjun Kim
Hanjun Kim
SZShiming Zhang
Shiming Zhang
XZXingwu Zhou
Xingwu Zhou
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

26 February 2020 in Small
Verified
Journal Article
Closed access
PDF file
JZJixiang Zhu
Jixiang Zhu
XZXingwu Zhou
Xingwu Zhou
HKHanjun Kim
Hanjun Kim
MQMoyuan Qu
Moyuan Qu
XJXing Jiang
Xing Jiang
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

3 March 2020 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
MQMoyuan Qu
Moyuan Qu
XJXing Jiang
Xing Jiang
XZXingwu Zhou
Xingwu Zhou
CWCanran Wang
Canran Wang
QWQingzhi Wu
Qingzhi Wu
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

4 May 2020 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
XZXingwu Zhou
Xingwu Zhou
ZLZhimin Luo
Zhimin Luo
ABAvijit Baidya
Avijit Baidya
HKHanjun Kim
Hanjun Kim
CWCanran Wang
Canran Wang
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

22 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
WSWujin Sun
Wujin Sun
JWJinqiang Wang
Jinqiang Wang
QHQuanyin Hu
Quanyin Hu
XZXingwu Zhou
Xingwu Zhou
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
ZGZhen Gu
Zhen Gu
CRISPR-Cas12a represents an efficient tool for genome editing in addition to the extensively investigated CRISPR-Cas9. However, development of efficient nonviral delivery system for CRISPR-Cas12a remains challenging. Here, we demonstrate a DNA nanoclew (NC)–based carrier for delivery of Cas12a/CRISPR RNA (crRNA) ribonucleoprotein (RNP) toward regulating serum cholesterol levels. The DNA NC could efficiently load the Cas12a/crRNA RNP through complementation between the DNA NC and the crRNA. Addition of a cationic polymer layer condensed the DNA-templated core and allowed further coating of a charge reversal polymer layer, which makes the assembly negatively charged under a physiological pH but reverts to positive charge under an acidic environment. When Pcsk9 was selected as the target gene because of its important role in regulating the level of serum cholesterol, efficient Pcsk9 disruption was observed in vivo (~48%), significantly reducing the expression of PCSK9 and gaining the therapeutic benefit of cholesterol control (~45% of cholesterol reduction).